Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graves Disease | 19 | 2016 | 239 | 1.610 |
Why?
|
Graves Ophthalmopathy | 4 | 2024 | 135 | 1.130 |
Why?
|
Thyroglobulin | 6 | 2021 | 111 | 0.930 |
Why?
|
Thyroid Gland | 14 | 2018 | 1170 | 0.890 |
Why?
|
Thyroiditis, Autoimmune | 11 | 2003 | 101 | 0.750 |
Why?
|
Thyroiditis | 2 | 2020 | 86 | 0.730 |
Why?
|
Receptors, Thyrotropin | 4 | 2022 | 45 | 0.650 |
Why?
|
Thyrotropin | 7 | 2016 | 834 | 0.600 |
Why?
|
Thyroid Neoplasms | 8 | 2021 | 2355 | 0.570 |
Why?
|
Thyroid Nodule | 5 | 2018 | 765 | 0.510 |
Why?
|
Hyperthyroidism | 5 | 2016 | 292 | 0.490 |
Why?
|
Biotin | 1 | 2016 | 255 | 0.480 |
Why?
|
Triiodothyronine | 3 | 2016 | 493 | 0.480 |
Why?
|
Thyroid Hormones | 3 | 2018 | 408 | 0.440 |
Why?
|
Thyroxine | 6 | 2016 | 666 | 0.440 |
Why?
|
Thyroid Diseases | 9 | 2018 | 385 | 0.410 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2012 | 60 | 0.380 |
Why?
|
Iodine Radioisotopes | 6 | 2012 | 1029 | 0.380 |
Why?
|
Lod Score | 9 | 2007 | 600 | 0.370 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2011 | 75 | 0.360 |
Why?
|
Pituitary Diseases | 1 | 2011 | 137 | 0.350 |
Why?
|
Autoantibodies | 11 | 2013 | 2114 | 0.350 |
Why?
|
Thyroidectomy | 4 | 2012 | 912 | 0.300 |
Why?
|
Hypothyroidism | 4 | 2011 | 667 | 0.280 |
Why?
|
Immunoconjugates | 4 | 2001 | 975 | 0.240 |
Why?
|
Autoimmunity | 2 | 2011 | 1361 | 0.240 |
Why?
|
Thyroid Function Tests | 2 | 2018 | 289 | 0.230 |
Why?
|
Exophthalmos | 2 | 2022 | 100 | 0.190 |
Why?
|
Aging | 5 | 2018 | 8729 | 0.190 |
Why?
|
Antigens, Differentiation | 5 | 2003 | 920 | 0.180 |
Why?
|
Antibodies, Heterophile | 1 | 2021 | 128 | 0.180 |
Why?
|
Glucocorticoids | 3 | 2022 | 2163 | 0.130 |
Why?
|
X Chromosome | 2 | 1999 | 819 | 0.130 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2012 | 323 | 0.120 |
Why?
|
Chromosomes, Human, Pair 14 | 4 | 1999 | 286 | 0.120 |
Why?
|
Tissue and Organ Harvesting | 1 | 2017 | 372 | 0.110 |
Why?
|
Living Donors | 1 | 2017 | 647 | 0.100 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15645 | 0.100 |
Why?
|
Immunity | 1 | 1998 | 1002 | 0.100 |
Why?
|
Ethanol | 1 | 2018 | 1330 | 0.100 |
Why?
|
Chromosomes, Human, Pair 2 | 3 | 2003 | 313 | 0.100 |
Why?
|
Methylprednisolone | 3 | 2022 | 386 | 0.100 |
Why?
|
Humans | 53 | 2024 | 767040 | 0.090 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 638 | 0.090 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 454 | 0.090 |
Why?
|
Ultrasonography | 3 | 2020 | 6000 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2020 | 1787 | 0.090 |
Why?
|
Paraganglioma | 1 | 2011 | 143 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 8 | 2007 | 18063 | 0.080 |
Why?
|
Microsatellite Repeats | 6 | 2003 | 784 | 0.080 |
Why?
|
Blood Glucose | 1 | 2024 | 6421 | 0.080 |
Why?
|
Chromosome Mapping | 7 | 2007 | 4616 | 0.080 |
Why?
|
Quality of Life | 3 | 2022 | 13485 | 0.080 |
Why?
|
Sex Characteristics | 2 | 1999 | 2647 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1278 | 0.080 |
Why?
|
Amiodarone | 1 | 2010 | 217 | 0.080 |
Why?
|
Autoimmune Diseases | 6 | 1999 | 2255 | 0.070 |
Why?
|
Receptors, Interleukin-2 | 3 | 1994 | 564 | 0.070 |
Why?
|
Lithium | 1 | 2010 | 600 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12986 | 0.070 |
Why?
|
Carcinoma, Papillary | 2 | 2007 | 791 | 0.070 |
Why?
|
Antibodies, Monoclonal | 3 | 2022 | 9245 | 0.070 |
Why?
|
Immunomodulation | 1 | 2010 | 548 | 0.070 |
Why?
|
Hashimoto Disease | 1 | 2007 | 108 | 0.060 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2010 | 773 | 0.060 |
Why?
|
Myasthenia Gravis | 2 | 2000 | 214 | 0.060 |
Why?
|
Genetic Linkage | 3 | 2001 | 2342 | 0.060 |
Why?
|
Drug Interactions | 1 | 2010 | 1419 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2007 | 735 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4256 | 0.060 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2007 | 219 | 0.060 |
Why?
|
Hormone Replacement Therapy | 1 | 2010 | 756 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2010 | 963 | 0.060 |
Why?
|
Antigens, CD | 5 | 2003 | 4032 | 0.060 |
Why?
|
Diplopia | 2 | 2022 | 217 | 0.050 |
Why?
|
Middle Aged | 23 | 2024 | 223233 | 0.050 |
Why?
|
Female | 37 | 2024 | 396660 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2016 | 3446 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3773 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7435 | 0.050 |
Why?
|
Aged | 20 | 2024 | 171319 | 0.050 |
Why?
|
Chromosomes, Human, Pair 20 | 2 | 1999 | 127 | 0.050 |
Why?
|
Male | 33 | 2024 | 364203 | 0.050 |
Why?
|
Survival Analysis | 2 | 2012 | 10092 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6844 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 897 | 0.050 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2001 | 56 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2428 | 0.050 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 36 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2001 | 373 | 0.040 |
Why?
|
Immunogenetics | 1 | 2000 | 62 | 0.040 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 120 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2018 | 65295 | 0.040 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 149 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2007 | 1626 | 0.040 |
Why?
|
Iodide Peroxidase | 3 | 1999 | 295 | 0.040 |
Why?
|
Sialoglycoproteins | 1 | 2000 | 316 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2024 | 2227 | 0.040 |
Why?
|
Goiter, Nodular | 1 | 1998 | 28 | 0.040 |
Why?
|
Aromatase | 1 | 1998 | 147 | 0.040 |
Why?
|
Adult | 22 | 2024 | 223317 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 2 | 2012 | 1131 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2010 | 3078 | 0.030 |
Why?
|
Italy | 2 | 2014 | 856 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1998 | 361 | 0.030 |
Why?
|
Prognosis | 2 | 2017 | 29963 | 0.030 |
Why?
|
Genetic Testing | 2 | 2007 | 3591 | 0.030 |
Why?
|
Symporters | 1 | 1999 | 363 | 0.030 |
Why?
|
Genetic Markers | 2 | 1998 | 2602 | 0.030 |
Why?
|
Serbia | 1 | 2014 | 13 | 0.030 |
Why?
|
HLA Antigens | 1 | 2000 | 1334 | 0.030 |
Why?
|
Genome, Human | 2 | 2007 | 4441 | 0.030 |
Why?
|
Translations | 1 | 2014 | 84 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 812 | 0.030 |
Why?
|
Environment | 1 | 2000 | 1120 | 0.030 |
Why?
|
Methimazole | 3 | 2000 | 41 | 0.030 |
Why?
|
Microsomes | 1 | 1994 | 252 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5693 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17542 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2012 | 39317 | 0.030 |
Why?
|
Pregnancy | 3 | 2013 | 30238 | 0.030 |
Why?
|
Denmark | 1 | 2014 | 776 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1382 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 74886 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5456 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2011 | 115 | 0.020 |
Why?
|
Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2012 | 81659 | 0.020 |
Why?
|
Antithyroid Agents | 2 | 2000 | 72 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2252 | 0.020 |
Why?
|
United States | 1 | 2018 | 72971 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2014 | 643 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1999 | 2568 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12451 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2277 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2531 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2012 | 492 | 0.020 |
Why?
|
Genotype | 2 | 2003 | 13035 | 0.020 |
Why?
|
Liver Function Tests | 1 | 1989 | 526 | 0.020 |
Why?
|
India | 1 | 2014 | 2334 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2011 | 514 | 0.020 |
Why?
|
Bile Acids and Salts | 1 | 1989 | 398 | 0.020 |
Why?
|
Peroxidase | 1 | 1990 | 610 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2011 | 343 | 0.020 |
Why?
|
Smoking | 2 | 2001 | 9081 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3431 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1500 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4210 | 0.020 |
Why?
|
North America | 2 | 1998 | 1287 | 0.020 |
Why?
|
Animals | 3 | 2010 | 168965 | 0.020 |
Why?
|
Language | 1 | 2014 | 1550 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3530 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2007 | 463 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1171 | 0.010 |
Why?
|
Hemagglutination Tests | 2 | 1994 | 76 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2003 | 6067 | 0.010 |
Why?
|
Reference Values | 2 | 2003 | 4918 | 0.010 |
Why?
|
Radioimmunoassay | 2 | 1994 | 861 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12158 | 0.010 |
Why?
|
Europe | 2 | 1998 | 3432 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1615 | 0.010 |
Why?
|
Sex Distribution | 1 | 2007 | 2276 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24299 | 0.010 |
Why?
|
Alleles | 2 | 2003 | 6893 | 0.010 |
Why?
|
Age Distribution | 1 | 2007 | 2870 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2003 | 624 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2003 | 855 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40154 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2003 | 996 | 0.010 |
Why?
|
Lymphotoxin-alpha | 1 | 2000 | 94 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13284 | 0.010 |
Why?
|
Heymann Nephritis Antigenic Complex | 1 | 1999 | 15 | 0.010 |
Why?
|
Aged, 80 and over | 7 | 2001 | 59548 | 0.010 |
Why?
|
Adolescent | 9 | 2001 | 89046 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2001 | 1377 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 1989 | 1959 | 0.010 |
Why?
|
Hemorrhage | 1 | 2011 | 3464 | 0.010 |
Why?
|
Eyelids | 1 | 2001 | 278 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2000 | 717 | 0.010 |
Why?
|
Orbit | 1 | 2002 | 459 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2000 | 299 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 1999 | 370 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10622 | 0.010 |
Why?
|
Sex Ratio | 1 | 1998 | 107 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 1999 | 216 | 0.010 |
Why?
|
Optic Nerve | 1 | 2001 | 568 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2001 | 1587 | 0.010 |
Why?
|
Thymus Hyperplasia | 1 | 1997 | 32 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 41718 | 0.010 |
Why?
|
Penetrance | 1 | 1998 | 388 | 0.010 |
Why?
|
Mutation | 1 | 2001 | 30211 | 0.010 |
Why?
|
Antibody Formation | 1 | 2001 | 1392 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2007 | 22254 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1994 | 3804 | 0.010 |
Why?
|
Puerperal Disorders | 1 | 1999 | 304 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18401 | 0.010 |
Why?
|
Immunoradiometric Assay | 1 | 1995 | 20 | 0.010 |
Why?
|
Thymoma | 1 | 1997 | 186 | 0.010 |
Why?
|
Lymphocyte Activation | 2 | 1999 | 5499 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2001 | 1804 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2850 | 0.010 |
Why?
|
Thymus Neoplasms | 1 | 1997 | 272 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 1998 | 1524 | 0.010 |
Why?
|
Gene Frequency | 1 | 2001 | 3621 | 0.010 |
Why?
|
Family Health | 1 | 1998 | 1254 | 0.010 |
Why?
|
Visual Fields | 1 | 2000 | 1063 | 0.010 |
Why?
|
Administration, Oral | 1 | 2001 | 4026 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1999 | 1250 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11063 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1994 | 570 | 0.010 |
Why?
|
Genome | 1 | 2001 | 1752 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1994 | 1141 | 0.010 |
Why?
|
Pregnancy Complications | 2 | 1999 | 2971 | 0.010 |
Why?
|
Family | 1 | 2003 | 3210 | 0.010 |
Why?
|
Child | 6 | 1999 | 80771 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2003 | 10254 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14672 | 0.010 |
Why?
|
Pedigree | 1 | 1998 | 4539 | 0.010 |
Why?
|
Linear Models | 1 | 2000 | 5875 | 0.010 |
Why?
|
Disabled Persons | 1 | 1999 | 1209 | 0.010 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1989 | 64 | 0.010 |
Why?
|
Prevalence | 1 | 2007 | 15851 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8535 | 0.010 |
Why?
|
gamma-Glutamyltransferase | 1 | 1989 | 143 | 0.010 |
Why?
|
Models, Genetic | 1 | 1998 | 3445 | 0.000 |
Why?
|
Lipids | 1 | 1999 | 3322 | 0.000 |
Why?
|
Hepatic Encephalopathy | 1 | 1989 | 143 | 0.000 |
Why?
|
Bone Density | 1 | 2001 | 3573 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1989 | 415 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1990 | 959 | 0.000 |
Why?
|
Membrane Glycoproteins | 1 | 1999 | 3702 | 0.000 |
Why?
|
Recurrence | 1 | 1999 | 8504 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1989 | 609 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1994 | 2900 | 0.000 |
Why?
|
Radiotherapy Dosage | 1 | 1993 | 2915 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1989 | 861 | 0.000 |
Why?
|
Computer Simulation | 1 | 1999 | 6260 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1990 | 2478 | 0.000 |
Why?
|
Carrier Proteins | 1 | 1999 | 4925 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16718 | 0.000 |
Why?
|
Longevity | 1 | 1992 | 1083 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2003 | 16036 | 0.000 |
Why?
|
Hepatitis B | 1 | 1989 | 710 | 0.000 |
Why?
|
Chronic Disease | 1 | 1999 | 9362 | 0.000 |
Why?
|
Carcinoma | 1 | 1995 | 2326 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1999 | 14766 | 0.000 |
Why?
|
Apoptosis | 1 | 1999 | 9513 | 0.000 |
Why?
|
Bone Neoplasms | 1 | 1994 | 2563 | 0.000 |
Why?
|
Prospective Studies | 2 | 2001 | 54886 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1999 | 7868 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1992 | 5891 | 0.000 |
Why?
|
Health Status | 1 | 1995 | 4091 | 0.000 |
Why?
|
Adenoma | 1 | 1991 | 2155 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1994 | 11217 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1992 | 4787 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 1997 | 15925 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20741 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1994 | 9410 | 0.000 |
Why?
|
Mice | 1 | 1999 | 81912 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1994 | 13491 | 0.000 |
Why?
|